U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry EPIMERIC
Molecular Formula C28H38NO4
Molecular Weight 452.6056
Optical Activity UNSPECIFIED
Defined Stereocenters 4 / 5
E/Z Centers 0
Charge 1

SHOW SMILES / InChI
Structure of BUTROPIUM

SMILES

CCCCOC1=CC=C(C[N@+]2(C)[C@H]3CC[C@@H]2C[C@@H](C3)OC(=O)[C@H](CO)C4=CC=CC=C4)C=C1

InChI

InChIKey=ALVDDLOWVXJXCD-OTSXCXJCSA-N
InChI=1S/C28H38NO4/c1-3-4-16-32-25-14-10-21(11-15-25)19-29(2)23-12-13-24(29)18-26(17-23)33-28(31)27(20-30)22-8-6-5-7-9-22/h5-11,14-15,23-24,26-27,30H,3-4,12-13,16-20H2,1-2H3/q+1/t23-,24+,26+,27-,29?/m1/s1

HIDE SMILES / InChI

Molecular Formula C28H37NO4
Molecular Weight 451.5977
Charge 0
Count
Stereochemistry MIXED
Additional Stereochemistry No
Defined Stereocenters 3 / 5
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: Description was created based on several sources, including http://www.mims.com/malaysia/drug/info/coliopan and http://www.genome.jp/dbget-bin/www_bget?D01491

Butropium Bromide is an anticholinergic and an antispasmodic. It is a Muscarinic receptor antagonist. The drug is used for remission of spasmodic pain in the following diseases: gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia). It is marketed in Japan under the brand name Coliopan.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Palliative
Coliopan

Approved Use

Remission of spasmodic pain in the following diseases: Gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia)

Launch Date

1974
Palliative
Coliopan

Approved Use

Remission of spasmodic pain in the following diseases: Gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia)

Launch Date

1974
Palliative
Coliopan

Approved Use

Remission of spasmodic pain in the following diseases: Gastritis, enteritis, gastric ulcer, duodenal ulcer, cholelithiasis and cholecystopathy (including cholecystitis, and cholecystic and biliary dyskinesia)

Launch Date

1974
PubMed

PubMed

TitleDatePubMed
Effect of glucagon on gastric motility examined by the acetaminophen absorption method and the endoscopic procedure.
1985
Patents

Sample Use Guides

In Vivo Use Guide
Curator's Comment: Can also be administered intramuscularly http://www.ncbi.nlm.nih.gov/pubmed/7182948
Capsules 5 mg: The usual adult dosage for oral use is 6 capsules (30 mg of butropium bromide) daily in three divided doses. Tablets 10 mg: The usual adult dosage for oral use is 3 tablets (30 mg of butropium bromide) daily in three divided doses. Granules 2 %: The usual adult dosage for oral use is 1.5 g (30 mg of butropium bromide) daily in three divided doses.
Route of Administration: Oral
In Vitro Use Guide
Unknown
Substance Class Chemical
Created
by admin
on Fri Dec 15 17:08:47 GMT 2023
Edited
by admin
on Fri Dec 15 17:08:47 GMT 2023
Record UNII
7WSK03KXXW
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
BUTROPIUM
WHO-DD  
Common Name English
8-AZONIABICYCLO(3.2.1)OCTANE, 8-((4-BUTOXYPHENYL)METHYL)-3-(3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-8-METHYL-, (3(S)-ENDO)-
Common Name English
8-(P-BUTOXYBENZYL)-3.ALPHA.-HYDROXY-1.ALPHA.H,5.ALPHA.H-TROPANIUM (-)-TROPATE
Common Name English
Butropium [WHO-DD]
Common Name English
BUTROPIUM CATION
Common Name English
BUTROPIUM ION
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C29704
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
Code System Code Type Description
PUBCHEM
656593
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
FDA UNII
7WSK03KXXW
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
EPA CompTox
DTXSID40860428
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
EVMPD
SUB00923MIG
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
CAS
107080-63-7
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
NCI_THESAURUS
C83569
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
SMS_ID
100000084862
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
DRUG CENTRAL
456
Created by admin on Fri Dec 15 17:08:47 GMT 2023 , Edited by admin on Fri Dec 15 17:08:47 GMT 2023
PRIMARY
Related Record Type Details
ACTIVE MOIETY